Brian B. Gowen
About
Brian B. Gowen is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Brian B. Gowen has authored 93 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Infectious Diseases, 23 papers in Epidemiology and 22 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Brian B. Gowen's work include Viral Infections and Vectors (67 papers), Viral Infections and Outbreaks Research (65 papers) and Mosquito-borne diseases and control (20 papers). Brian B. Gowen is often cited by papers focused on Viral Infections and Vectors (67 papers), Viral Infections and Outbreaks Research (65 papers) and Mosquito-borne diseases and control (20 papers). Brian B. Gowen collaborates with scholars based in United States, Japan and Canada. Brian B. Gowen's co-authors include Yousuke Furuta, Donald F. Smee, Dale L. Barnard, Kazumi Takahashi, Kimíyasu Shiraki, Kie‐Hoon Jung, Min‐Hui Wong, Jonna B. Westover, Kevin W. Bailey and B. Joseph Hinnebusch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Immunology.
In The Last Decade
Brian B. Gowen
91 papers receiving 4.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Brian B. Gowen United States | 34 | 2.8k | 1.1k | 804 | 669 | 657 | 93 | 4.4k | ||
| Alexander N. Freiberg United States | 34 | 2.4k 0.8× | 1.3k 1.1× | 628 0.8× | 813 1.2× | 741 1.1× | 110 | 4.0k | ||
| Yousuke Furuta Japan | 33 | 3.5k 1.2× | 2.1k 1.8× | 689 0.9× | 750 1.1× | 521 0.8× | 57 | 5.1k | ||
| Dana Scott United States | 43 | 5.4k 1.9× | 1.9k 1.6× | 886 1.1× | 711 1.1× | 581 0.9× | 107 | 6.7k | ||
| Masayuki Shimojima Japan | 35 | 2.8k 1.0× | 1.2k 1.0× | 624 0.8× | 553 0.8× | 547 0.8× | 155 | 4.3k | ||
| Michael R. Holbrook United States | 38 | 3.4k 1.2× | 973 0.9× | 1.6k 2.0× | 661 1.0× | 478 0.7× | 107 | 4.6k | ||
| Friederike Feldmann United States | 47 | 6.1k 2.2× | 2.8k 2.4× | 579 0.7× | 970 1.4× | 908 1.4× | 146 | 8.0k | ||
| David Safronetz Canada | 36 | 2.9k 1.0× | 1.1k 0.9× | 1.1k 1.4× | 442 0.7× | 223 0.3× | 132 | 3.7k | ||
| Masayuki Saijo Japan | 43 | 4.5k 1.6× | 1.8k 1.6× | 1.6k 2.0× | 1.0k 1.5× | 528 0.8× | 342 | 6.9k | ||
| Mike Bray United States | 50 | 5.7k 2.0× | 3.1k 2.7× | 919 1.1× | 1.3k 1.9× | 1.0k 1.6× | 96 | 8.6k | ||
| John W. Huggins United States | 46 | 3.0k 1.1× | 2.5k 2.2× | 656 0.8× | 2.3k 3.4× | 629 1.0× | 102 | 6.6k |
Countries citing papers authored by Brian B. Gowen
Since
Specialization
Citations
This map shows the geographic impact of Brian B. Gowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian B. Gowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian B. Gowen more than expected).
Fields of papers citing papers by Brian B. Gowen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Brian B. Gowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian B. Gowen. The network helps show where Brian B. Gowen may publish in the future.
Co-authorship network of co-authors of Brian B. Gowen
This figure shows the co-authorship network connecting the top 25 collaborators of Brian B. Gowen. A scholar is included among the top collaborators of Brian B. Gowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian B. Gowen. Brian B. Gowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Manzoni, Tomaz B., Jonna B. Westover, Kendall A. Lundgreen, et al.. (2025). Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein. Viruses. 17(8). 1095–1095.
2.
Westover, Jonna B., Kevin W. Bailey, Alexander A. Kolykhalov, et al.. (2025). Effective treatment of advanced Oropouche virus, Rift Valley fever virus, and Dabie bandavirus infections with 4'-fluorouridine. mBio. 16(10). e0146725–e0146725.
3.
Hicks, Philip, Tomaz B. Manzoni, Jonna B. Westover, et al.. (2024). Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus. Vaccines. 12(12). 1403–1403.
4.
Hulswit, Ruben J. G., Jonna B. Westover, Guido C. Paesen, et al.. (2023). Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses. Nature Communications. 14(1). 5650–5650.
5.
Gowen, Brian B., et al.. (2021). Potent inhibition of arenavirus infection by a novel fusion inhibitor. Antiviral Research. 193. 105125–105125.
6.
Gowen, Brian B., Brady T. Hickerson, Joanne York, et al.. (2021). Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junín Virus Infection in Guinea Pigs. Journal of Virology. 95(14). e0039721–e0039721.
7.
Zhao, Haiyan, Nurgun Kose, Jonna B. Westover, et al.. (2021). Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition. Proceedings of the National Academy of Sciences. 118(14).
8.
Hawman, David W., Elaine Haddock, Kimberly Meade‐White, et al.. (2020). Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques. Antiviral Research. 181. 104858–104858.
9.
Monath, Thomas P., Jeroen Kortekaas, Douglas M. Watts, et al.. (2020). Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile. Vaccine X. 5. 100060–100060.
10.
Westover, Jonna B., Brady T. Hickerson, Arnaud J. Van Wettere, et al.. (2019). Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice. Pathogens. 8(4). 158–158.
11.
Hawman, David W., Elaine Haddock, Kimberly Meade‐White, et al.. (2018). Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antiviral Research. 157. 18–26.
12.
Gowen, Brian B., Jonna B. Westover, Eric J. Sefing, et al.. (2017). Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy. Antiviral Research. 145. 131–135.
13.
Ennis, Jane, et al.. (2014). Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201). Antiviral Research. 108. 1–9.
14.
Gowen, Brian B., Terry L. Juelich, Eric J. Sefing, et al.. (2013). Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever. PLoS neglected tropical diseases. 7(12). e2614–e2614.
15.
Furuta, Yousuke, Kazumi Takahashi, Kimíyasu Shiraki, et al.. (2009). T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Research. 82(3). 95–102.
16.
Mendenhall, Michelle, Min‐Hui Wong, Ramona T. Skirpstunas, John D. Morrey, & Brian B. Gowen. (2009). Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: Strain differences in pathogenesis and host interferon response. Virology. 395(1). 143–151.
17.
Gowen, Brian B., Donald F. Smee, Jeffery O. Hall, et al.. (2008). T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model:T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to RibavirinTherapy. PLoS ONE. 3(11). 3725.
18.
Gowen, Brian B., Min‐Hui Wong, Kie‐Hoon Jung, Lawrence M. Blatt, & Robert W. Sidwell. (2008). Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1. Antiviral Research. 77(3). 215–224.
19.
Gowen, Brian B., et al.. (2008). Immunoprophylaxis of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with recombinant Eimeria profilin-like antigen. International Immunopharmacology. 8(8). 1089–1094.
20.
Gowen, Brian B. & Michael R. Holbrook. (2007). Animal models of highly pathogenic RNA viral infections: Hemorrhagic fever viruses. Antiviral Research. 78(1). 79–90.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Alexander N. Freiberg Breakdown of academic impact, for papers by Yousuke Furuta Breakdown of academic impact, for papers by Dana Scott Breakdown of academic impact, for papers by Masayuki Shimojima Breakdown of academic impact, for papers by Michael R. Holbrook Breakdown of academic impact, for papers by Friederike Feldmann Breakdown of academic impact, for papers by David Safronetz Breakdown of academic impact, for papers by Masayuki Saijo Breakdown of academic impact, for papers by Mike Bray Breakdown of academic impact, for papers by John W. Huggins